NDRA
Endra Life Sciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 2
Consensus Rating "Strong Buy"
MACD Death Cross
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About NDRA
Endra Life Sciences Inc.
A Healthcare company that develops and commercialize an ultrasound technology for the pre-clinical research market
Healthcare Equipment and Supplies
07/18/2007
06/28/2017
NASDAQ Stock Exchange
21
12-31
Common stock
3600 Green Court
, Suite 350
, Ann Arbor
, MI 48105-1570
--
Endra Life Sciences Corporation was incorporated as a Delaware corporation on July 18, 2007. Endra has developed a thermoacoustic effect-based medical imaging technology that significantly improves the sensitivity and specificity of clinical ultrasound. Since 2010, Endra has listed and sold the company's Nexus 128 system based on thermoacoustic and ultrasound imaging combined with light to meet the imaging needs of researchers studying disease models in preclinical applications.
Company Financials
EPS
NDRA has released its 2025 Q3 earnings. EPS was reported at -2.1, versus the expected -1.95, missing expectations. The chart below visualizes how NDRA has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
